Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

AVEO Pharmaceuticals Price to Sales Ratio 2009-2019 | AVEO

Historical PS ratio values for AVEO Pharmaceuticals (AVEO) over the last 10 years. The current P/S ratio for AVEO Pharmaceuticals as of October 11, 2019 is .
  
AVEO Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-10-11 0.83 17.12
2019-06-30 0.67 $0.05 13.90
2019-03-31 0.82 $0.05 17.31
2018-12-31 1.60 $0.04 36.47
2018-09-30 3.31 $0.03 99.38
2018-06-30 2.26 $0.05 43.57
2018-03-31 2.90 $0.05 56.11
2017-12-31 2.79 $0.08 36.59
2017-09-30 3.65 $0.08 47.21
2017-06-30 2.22 $0.05 43.28
2017-03-31 0.59 $0.05 11.57
2016-12-31 0.54 $0.04 14.03
2016-09-30 0.89 $0.10 8.79
2016-06-30 0.96 $0.35 2.71
2016-03-31 0.92 $0.35 2.60
2015-12-31 1.26 $0.34 3.76
2015-09-30 1.21 $0.27 4.43
2015-06-30 1.74 $0.02 72.39
2015-03-31 1.45 $0.06 25.29
2014-12-31 0.84 $0.35 2.39
2014-09-30 1.11 $0.36 3.13
2014-06-30 1.83 $0.34 5.31
2014-03-31 1.50 $0.32 4.75
2013-12-31 1.83 $0.03 71.83
2013-09-30 2.06 $0.38 5.46
2013-06-30 2.50 $0.39 6.34
2013-03-31 7.35 $0.43 17.04
2012-12-31 8.05 $0.44 18.10
2012-09-30 10.41 $0.11 92.06
2012-06-30 12.16 $0.17 70.30
2012-03-31 12.41 $0.85 14.60
2011-12-31 17.20 $4.40 3.91
2011-09-30 15.39 $4.84 3.18
2011-06-30 20.61 $4.95 4.16
2011-03-31 13.32 $4.74 2.81
2010-12-31 14.62 $2.89 5.06
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.132B $0.005B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.149B 13.57
Gilead Sciences (GILD) United States $80.116B 9.84
CSL (CSLLY) Australia $74.068B 0.00
Celgene (CELG) United States $70.739B 10.94
Illumina (ILMN) United States $43.832B 51.50
Vertex Pharmaceuticals (VRTX) United States $43.753B 47.28
Biogen (BIIB) United States $41.132B 7.31
Regeneron Pharmaceuticals (REGN) United States $32.769B 14.87
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.053B 11.63
Incyte (INCY) United States $16.296B 47.96
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $15.610B 0.00
Seattle Genetics (SGEN) United States $13.188B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.935B 0.00
Genmab (GNMSF) Denmark $11.848B 66.46
Exact Sciences (EXAS) United States $11.721B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.634B 0.00
Galapagos (GLPG) Belgium $8.634B 0.00
Bio-Techne Corp (TECH) United States $7.559B 52.22
Sarepta Therapeutics (SRPT) United States $6.182B 0.00
QIAGEN (QGEN) Netherlands $6.143B 20.18
ACADIA Pharmaceuticals (ACAD) United States $5.849B 0.00
Guardant Health (GH) United States $5.630B 0.00
BeiGene (BGNE) Cayman Islands $5.534B 0.00
Amarin (AMRN) Ireland $5.326B 0.00
Exelixis (EXEL) United States $5.007B 13.02
Bluebird Bio (BLUE) United States $4.936B 0.00
Horizon Therapeutics Public (HZNP) Ireland $4.911B 12.48
Moderna (MRNA) United States $4.675B 0.00
China Biologic Products (CBPO) China $4.540B 28.34
ARGENX SE-ADR (ARGX) Netherlands $4.204B 0.00
Medicines (MDCO) United States $4.154B 0.00
Repligen (RGEN) United States $3.911B 75.90
Ascendis Pharma (ASND) Denmark $3.890B 0.00
Spark Therapeutics (ONCE) United States $3.704B 0.00
Blueprint Medicines (BPMC) United States $3.533B 0.00
MorphoSys AG (MOR) Germany $3.373B 0.00
Mirati Therapeutics (MRTX) United States $2.977B 0.00
Alkermes (ALKS) Ireland $2.717B 0.00
Emergent Biosolutions (EBS) United States $2.709B 40.70
Immunomedics (IMMU) United States $2.686B 0.00
Reata Pharmaceuticals (RETA) United States $2.588B 0.00
Genomic Health (GHDX) United States $2.532B 47.48
Genmab (GMAB) Denmark $2.491B 0.00
MyoKardia (MYOK) United States $2.459B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.409B 0.00
Arena Pharmaceuticals (ARNA) United States $2.317B 4.98
Halozyme Therapeutics (HALO) United States $2.288B 0.00
RA PHARMCTL INC (RARX) United States $2.146B 0.00
Myriad Genetics (MYGN) United States $2.130B 22.36
NeoGenomics (NEO) United States $2.041B 109.17
Acceleron Pharma (XLRN) United States $2.022B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.012B 0.00
Cambrex (CBM) United States $2.005B 25.35
Ligand Pharmaceuticals (LGND) United States $1.954B 24.71
Amicus Therapeutics (FOLD) United States $1.940B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.926B 0.00
Zai Lab (ZLAB) China $1.887B 0.00
Akcea Therapeutics (AKCA) United States $1.829B 0.00
UniQure (QURE) Netherlands $1.595B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.583B 0.00
Denali Therapeutics (DNLI) United States $1.457B 0.00
Insmed (INSM) United States $1.438B 0.00
REGENXBIO (RGNX) United States $1.433B 0.00
Coherus BioSciences (CHRS) United States $1.300B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.293B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.276B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.092B 0.00
Innoviva (INVA) United States $1.081B 3.12
Zymeworks (ZYME) Canada $1.053B 0.00
Alector (ALEC) United States $1.000B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.969B 0.00
Editas Medicine (EDIT) United States $0.965B 0.00
AnaptysBio (ANAB) United States $0.942B 0.00
Sangamo Therapeutics (SGMO) United States $0.931B 0.00
Fate Therapeutics (FATE) United States $0.915B 0.00
Epizyme (EPZM) United States $0.908B 0.00
Athenex (ATNX) United States $0.872B 0.00
ANI Pharmaceuticals (ANIP) United States $0.863B 14.41
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.776B 27.45
Codexis (CDXS) United States $0.767B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
Zealand Pharma (ZEAL) Denmark $0.747B 8.38
Cara Therapeutics (CARA) United States $0.745B 0.00
Twist Bioscience (TWST) United States $0.727B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.686B 0.00
Principia Biopharma (PRNB) United States $0.670B 346.75
Vanda Pharmaceuticals (VNDA) United States $0.670B 24.17
WAVE Life Sciences (WVE) Singapore $0.657B 0.00
Cytokineticsorporated (CYTK) United States $0.632B 0.00
Vericel (VCEL) United States $0.626B 0.00
Mesoblast (MESO) Australia $0.624B 0.00
Arvinas (ARVN) United States $0.589B 0.00
Heska (HSKA) United States $0.566B 73.32
MiMedx (MDXG) United States $0.564B 0.00
Intellia Therapeutics (NTLA) United States $0.531B 0.00
GENFIT S.A (GNFT) France $0.517B 0.00
Revance Therapeutics (RVNC) United States $0.514B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.509B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.502B 0.00
Retrophin (RTRX) United States $0.476B 0.00
PHARMA MAR SA (PHMMF) Spain $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.442B 0.00
Intra-Cellular Therapies (ITCI) United States $0.438B 0.00
Cellectis S.A (CLLS) France $0.419B 0.00
BioDelivery Sciences (BDSI) United States $0.418B 0.00
DBV Technologies S.A (DBVT) France $0.411B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.407B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.387B 0.00
Stemline Therapeutics (STML) United States $0.378B 0.00
Precision BioSciences (DTIL) United States $0.375B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
Syros Pharmaceuticals (SYRS) United States $0.368B 0.00
Arcus Biosciences (RCUS) United States $0.367B 0.00
Bellus Health (BLU) Canada $0.361B 0.00
Agenus (AGEN) United States $0.358B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.358B 0.00
Kadmon Holdings (KDMN) United States $0.336B 0.00
Adverum Biotechnologies (ADVM) United States $0.333B 0.00
AC Immune SA (ACIU) Switzerland $0.326B 24.15
CytomX Therapeutics (CTMX) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.316B 0.00
Protagonist Therapeutics (PTGX) United States $0.304B 0.00
Starpharma Holdings (SPHRY) Australia $0.301B 0.00
Prothena (PRTA) Ireland $0.298B 0.00
Avid Bioservices (CDMO) United States $0.295B 0.00
Theratechnologies (THTX) Canada $0.285B 0.00
Puma Biotechnology (PBYI) United States $0.282B 0.00
PDL BioPharma (PDLI) United States $0.275B 7.09
Scholar Rock Holding (SRRK) United States $0.274B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Geron (GERN) United States $0.271B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Dynavax Technologies (DVAX) United States $0.258B 0.00
Kindred Biosciences (KIN) United States $0.245B 0.00
MannKind (MNKD) United States $0.241B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.231B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.220B 0.00
Albireo Pharma (ALBO) United States $0.217B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.216B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
Inovio Pharmaceuticals (INO) United States $0.214B 0.00
OSMOTICA PHARM (OSMT) United States $0.213B 0.00
Seres Therapeutics (MCRB) United States $0.213B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.210B 0.00
Compugen (CGEN) Israel $0.207B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.77
Athersys (ATHX) United States $0.202B 0.00
Spero Therapeutics (SPRO) United States $0.198B 0.00
Sorrento Therapeutics (SRNE) United States $0.191B 0.00
ChromaDex (CDXC) United States $0.189B 0.00
Exicure (XCUR) United States $0.179B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.177B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Clovis Oncology (CLVS) United States $0.173B 0.00
Cue Biopharma (CUE) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.166B 0.00
Affimed (AFMD) Germany $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.161B 0.00
XOMA (XOMA) United States $0.158B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
Five Prime Therapeutics (FPRX) United States $0.156B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.154B 0.00
Alcobra (ARCT) United States $0.150B 0.00
Arsanis (XFOR) United States $0.146B 0.00
Senesco Technologies (ELOX) United States $0.142B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.139B 0.00
Northwest Biotherapeutics (NWBO) United States $0.137B 0.00
Cerecor (CERC) United States $0.137B 0.00
Acorda Therapeutics (ACOR) United States $0.128B 0.00
NantKwest (NK) United States $0.125B 0.00
PHASEBIO PHARMA (PHAS) United States $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Strongbridge Biopharma (SBBP) United States $0.112B 4.60
Menlo Therapeutics (MNLO) United States $0.111B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.111B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Novavax (NVAX) United States $0.107B 0.00
Aptinyx (APTX) United States $0.104B 0.00
Emmaus Life Sciences (EMMA) United States $0.100B 0.00
Celyad SA (CYAD) Belgium $0.098B 0.00
OvaScience (MLND) United States $0.094B 0.00
VBI Vaccines (VBIV) United States $0.092B 0.00
Fortress Biotech (FBIO) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.086B 0.00
Aduro Biotech (ADRO) United States $0.084B 0.00
Verastem (VSTM) United States $0.083B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Mersana Therapeutics (MRSN) United States $0.077B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Liquidia Technologies (LQDA) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.069B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Orgenesis (ORGS) United States $0.058B 21.12
Merrimack Pharmaceuticals (MACK) United States $0.058B 0.00
Applied Genetic Technologies (AGTC) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.053B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.051B 0.00
Arbutus Biopharma (ABUS) Canada $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Unum Therapeutics (UMRX) United States $0.045B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Ophthotech (ISEE) United States $0.042B 0.00
Evogene (EVGN) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Proteostasis Therapeutics (PTI) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.035B 0.00
Celsion (CLSN) United States $0.035B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
Clearside Biomedical (CLSD) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
BioCardia (BCDA) United States $0.024B 0.00
Caladrius Biosciences (CLBS) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
DiaMedica Therapeutics (DMAC) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00